Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12609001059257
ACTRN12609001059257
Recruiting
Phase 2

Gonadotropin-releasing hormone analogue cotreatment does not preserve ovarian function in young women receiving cyclophosphamide-based chemotherapy: a prospective, multicenter, randomized trial

Ass. Prof. Dr. Eman Elgindy0 sites100 target enrollmentDecember 10, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsWomen of reproductive age receiving chemotherapyCancerReproductive Health and Childbirth - Fertility including in vitro fertilisationCancer - Breast

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Women of reproductive age receiving chemotherapy
Sponsor
Ass. Prof. Dr. Eman Elgindy
Enrollment
100
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Ass. Prof. Dr. Eman Elgindy

Eligibility Criteria

Inclusion Criteria

  • •Women between 18 and 40 years old receiving cyclophosphamide\-based chemotherapy for treatment of cancer with presence of both ovaries and absence of ovarian tumours or cysts over 40 mm in diameter demonstrated by transvaginal ultrasound

Exclusion Criteria

  • •Advanced stage disease or evidence of metastases; Cancer of the ovaries, uterus, or fallopian tubes; Women who previously received chemotherapy or abdominal/pelvic radiation or are planned to receive abdomino\-pelvic radiation; Patients taking hormone therapy biologic therapy or corticosteroids; Women who are pregnant or nursing.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter studyDiseases of The genitoruinary system
KCT0003286Bundang CHA General Hospital65
Unknown
Not Applicable
Antagonist versus agonist protocols: in patients with polycystic ovary syndrome treated for ICSI cyclesFertility-femaleInfertility in PCOS patients
PACTR201411000933365Obestetrics and Gynaecology Department, Faculty of Medicine, University of Alexandria200
Completed
Not Applicable
Gonadotropin releasing hormone agonist flare-up versus gonatotropin releasing hormone antagonist protocols in poor responders undergoing ICSI:RCT
PACTR201704002212265Airforce specialized hospital106
Completed
Not Applicable
GnRH-agonist trigger versus HCG trigger in cases of controlled ovaria
PACTR202001787868341faculty of medicine alexandria university300
Completed
Phase 2
Effect of Gonadotropin-releasing hormone analogue( GnRh-a ) for in vitro fertillization cycles (IVF)
IRCT20160722029027N7Shahid Beheshti University of Medical Sciences72